Delivery Order SPE2DB20D9759-SPE2DB24FD5JQ
Award Date 1/14/24
Potential Completion Date 2/5/24
Potential Value $3.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the SKYLA 13.5 MG SYSTEMS medical device. The $9,415.00 contract has a completion date of February 1, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription drugs, over-the-counter products, and medical supplies to support military treatment facilities worldwide under various...
- This is a $1,822.36 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business. The delivery order is for the supply of a pharmaceutical product called SKYLA 13.5 MG SYSTEMS. DMS Pharmaceutical Group holds a broader indefinite delivery contract with DLA to provide various medical supplies and pharmaceutical items to military treatment facilities worldwide. This specific delivery order is not associated...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a completion date of February 13, 2024 and a potential value of $7,061.25. It is for the delivery of SKYLA 13.5 MG SYSTEMS, a pharmaceutical product, to support the medical needs of the Department of Defense. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,486.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for SKYLA 13.5 mg systems. The award, made on August 5, 2025, with an ultimate completion date of August 26, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of SKYLA 13.5 MG SYSTEMS. The contract has a ceiling value of $9,415.00 and a period of performance through April 11, 2024. This delivery order is placed against a larger indefinite delivery contract, SPE2DB, held by DMS Pharmaceutical Group with DLA, valued up to $4,999,999 through the end of 2025. The SPE2DB contract enables DLA to issue...
- The Defense Logistics Agency (DLA) has awarded a $2,824.56 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of SKYLA 13.5 MG SYSTEMS and is valid through October 18, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,822.36 contract is for the delivery of SKYLA 13.5 MG SYSTEMS, a specialized pharmaceutical product, with a performance period through March 16, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,236.75, is for the delivery of Skyla 13.5 mg systems, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,270.95, is for the delivery of SKYLA 13.5 MG SYSTEMS, a pharmaceutical product, with a performance period through May 13, 2024. The contract is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, under the SPE2DB...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $23,537.50 firm fixed-price delivery order is for SKYLA 13.5 MG SYSTEMS and has an ultimate completion date of October 9, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...